developmentstoday

Ask DT AI Audio Brief Videos Podcast +

Ask DT AI Audio Brief Videos Podcast

HomeTagsAstraZeneca

#AstraZeneca

All articles tagged with "AstraZeneca"

Company

About Us
Advertise
Contact
Editorial Policy

Legal

Terms of Service
Privacy Policy
Cookie Policy
AI & Ethics Policy
Do Not Sell My Info
FAQ
Archive
Site Map

Discover

Newsletter
Ask DT AI
Audio Brief
Videos
Podcast
DT Premium

Connect

Twitter / X
Facebook
LinkedIn
YouTube
Instagram
TikTok
Flipboard
RSS Feed

© 2026 Developments Today. All rights reserved.

Gilead and Merck's latest trial success and flop

Gilead and Merck's Latest Trial Success and Flop: Biotech Roundup

Gilead and Merck had one successful trial and one failed trial.
AstraZeneca's oral GLP-1 pill showed positive Phase 2b results.
GSK acquired a cancer startup for $10.6 billion.
Other news: Regeneron's Eylea, Bluebird Bio gene therapy approval, FDA rejection.

DE

DT Editorial Team·Jun 10, 2026·via statnews.com

More in Health→

AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

AstraZeneca's Oral GLP-1 Pill Shows Promise in Mid-Stage Obesity and Diabetes Trials

AstraZeneca's oral GLP-1 pill showed 12% average weight loss in Phase 2 obesity trial.
Diabetes patients achieved significant HbA1c reductions with the once-daily pill.
Safety profile consistent with GLP-1 class; GI side effects mild to moderate.
Analysts say it's too early to compare with Novo Nordisk's Rybelsus or Lilly's orforglipron.

DE

DT Editorial Team·Jun 9, 2026·via statnews.com

More in Health→

FDA

FDA Oncology Advisers Reject AstraZeneca’s Trial Framing in Breast Cancer Review

FDA oncology advisers voted 6-3 against the clinical meaningfulness of AstraZeneca’s trial results.
The panel pushed back on what was described as a proposed new paradigm.
The vote signals regulatory skepticism, though it does not by itself determine final FDA action.

DE

DT Editorial Team·May 3, 2026·via endpoints.news

More in Health→

FDA announces real-time clinical trial data effort, with AstraZeneca and Amgen as test cases

FDA Tests a New Regulatory Model With Real-Time Clinical Trial Data

The FDA is launching a pilot to collect and review clinical trial data in real time.
AstraZeneca and Amgen are the first companies participating in the program.
The effort could shift regulatory review toward earlier and more continuous oversight of ongoing studies.

DE

DT Editorial Team·Apr 28, 2026·via endpoints.news

More in Health→